By comprehensive analysis of the expression (Figure 1) and prognosis (Figure 2) of BAIAP2L2 across cancers, we found that BAIAP2L2 was overexpressed in LIHC and was closely associated with poor prognosis of liver cancer patients (Figure 4), implying its importance in predicting the clinical outcome of LIHC. Here, BAIAP2L2 is linked to liver cancer.